Literature DB >> 13160443

Radio-iodine measurements of thyroid function during and after P.A.S. treatment of tuberculosis.

J A BALINT, R FRASER, M G HANNO.   

Abstract

Entities:  

Keywords:  IODINE/radioactive; PARA-AMINOSALICYLIC ACID/therapeutic use; THYROID GLAND/function tests; TUBERCULOSIS/therapy

Mesh:

Substances:

Year:  1954        PMID: 13160443      PMCID: PMC2085082          DOI: 10.1136/bmj.1.4873.1234

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  8 in total

1.  Effect of P.A.S. on the thyroid gland.

Authors:  R R HAMILTON
Journal:  Br Med J       Date:  1953-01-03

2.  Goitre and hypothyroidism developing during treatment with P.A.S.

Authors:  H T DAVIES; H J B GALBRAITH
Journal:  Br Med J       Date:  1953-06-06

3.  A case of myxoedema developing during p-aminosalicylic acid therapy.

Authors:  G M KOMROWER
Journal:  Br Med J       Date:  1951-11-17

4.  Antithyroid effect of p-amino-salicylic acid and m-aminophenol.

Authors:  K KJERULF-JENSEN; G WOLFFBRANDT
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1951

5.  [Fatal hypothyroid goiter and cerebral edema caused by conteben].

Authors:  N BERGQVIST; O de MARE
Journal:  Nord Med       Date:  1951-03-28

6.  [Artificial myxedema during para-aminosalicylic acid therapy].

Authors:  K H CLAUSEN; K KJERULF-JENSEN
Journal:  Nord Med       Date:  1951-03-28

7.  Determination of the antithyroid action of para-aminosalicylic acid using radioactive iodine.

Authors:  A HANNGREN
Journal:  Lancet       Date:  1952-07-19       Impact factor: 79.321

8.  Paraaminosalicylic acid in tuberculosis; clinical and pharmacological aspects.

Authors:  D G MADIGAN; L L GRIFFITHS
Journal:  Lancet       Date:  1950-02-11       Impact factor: 79.321

  8 in total
  3 in total

1.  The mode of action of antithyroid drugs: further observations on in vitro inhibition of oxidative protein iodination.

Authors:  R FRASER; M G HANNO; W R PITNEY
Journal:  Br J Pharmacol Chemother       Date:  1955-03

2.  Hyperthyroidism developing during P.A.S. therapy.

Authors:  S TANDHANAND; R BURI
Journal:  Br Med J       Date:  1956-08-04

Review 3.  Safety and tolerability profile of second-line anti-tuberculosis medications.

Authors:  Geetha Ramachandran; Soumya Swaminathan
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.